vs
Addus HomeCare Corp（ADUS）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Addus HomeCare Corp的3.8倍（$1.4B vs $373.1M）。Addus HomeCare Corp净利率更高（8.0% vs 3.6%，领先4.4%）。Addus HomeCare Corp同比增速更快（25.6% vs 12.2%）。通用电气医疗自由现金流更多（$130.2M vs $16.1M）。过去两年Addus HomeCare Corp的营收复合增速更高（15.3% vs 13.0%）
Addus HomeCare Corp是一家总部位于美国的家庭护理服务提供商，主要为老年人、残障人士及慢性病患者提供个人护理、居家健康支持、临终关怀等服务，业务覆盖美国多个州，合作方包括政府支付机构、私营保险公司及个人客户。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
ADUS vs OPCH — 直观对比
营收规模更大
OPCH
是对方的3.8倍
$373.1M
营收增速更快
ADUS
高出13.3%
12.2%
净利率更高
ADUS
高出4.4%
3.6%
自由现金流更多
OPCH
多$114.1M
$16.1M
两年增速更快
ADUS
近两年复合增速
13.0%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $373.1M | $1.4B |
| 净利润 | $29.8M | $51.8M |
| 毛利率 | 33.1% | 19.0% |
| 营业利润率 | 11.3% | 5.9% |
| 净利率 | 8.0% | 3.6% |
| 营收同比 | 25.6% | 12.2% |
| 净利润同比 | 52.5% | -3.8% |
| 每股收益（稀释后） | $1.62 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADUSOPCH
| Q4 25 | $373.1M | — | ||
| Q3 25 | $362.3M | $1.4B | ||
| Q2 25 | $349.4M | $1.4B | ||
| Q1 25 | $337.7M | $1.3B | ||
| Q4 24 | $297.1M | $1.3B | ||
| Q3 24 | $289.8M | $1.3B | ||
| Q2 24 | $286.9M | $1.2B | ||
| Q1 24 | $280.7M | $1.1B |
净利润ADUSOPCH
| Q4 25 | $29.8M | — | ||
| Q3 25 | $22.8M | $51.8M | ||
| Q2 25 | $22.1M | $50.5M | ||
| Q1 25 | $21.2M | $46.7M | ||
| Q4 24 | $19.5M | $60.1M | ||
| Q3 24 | $20.2M | $53.9M | ||
| Q2 24 | $18.1M | $53.0M | ||
| Q1 24 | $15.8M | $44.8M |
毛利率ADUSOPCH
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.2% | 19.0% | ||
| Q2 25 | 32.6% | 19.0% | ||
| Q1 25 | 31.9% | 19.7% | ||
| Q4 24 | 34.2% | 21.3% | ||
| Q3 24 | 31.8% | 20.1% | ||
| Q2 24 | 32.5% | 20.3% | ||
| Q1 24 | 31.4% | 20.8% |
营业利润率ADUSOPCH
| Q4 25 | 11.3% | — | ||
| Q3 25 | 9.1% | 5.9% | ||
| Q2 25 | 9.4% | 5.8% | ||
| Q1 25 | 9.0% | 5.9% | ||
| Q4 24 | 9.1% | 6.9% | ||
| Q3 24 | 9.0% | 6.7% | ||
| Q2 24 | 9.1% | 6.6% | ||
| Q1 24 | 8.4% | 6.0% |
净利率ADUSOPCH
| Q4 25 | 8.0% | — | ||
| Q3 25 | 6.3% | 3.6% | ||
| Q2 25 | 6.3% | 3.6% | ||
| Q1 25 | 6.3% | 3.5% | ||
| Q4 24 | 6.6% | 4.8% | ||
| Q3 24 | 7.0% | 4.2% | ||
| Q2 24 | 6.3% | 4.3% | ||
| Q1 24 | 5.6% | 3.9% |
每股收益（稀释后）ADUSOPCH
| Q4 25 | $1.62 | — | ||
| Q3 25 | $1.24 | $0.32 | ||
| Q2 25 | $1.20 | $0.31 | ||
| Q1 25 | $1.16 | $0.28 | ||
| Q4 24 | $1.06 | $0.36 | ||
| Q3 24 | $1.10 | $0.31 | ||
| Q2 24 | $1.10 | $0.30 | ||
| Q1 24 | $0.97 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $309.8M |
| 总债务越低越好 | $121.0M | $1.2B |
| 股东权益账面价值 | $1.1B | $1.4B |
| 总资产 | $1.4B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.11× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资ADUSOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | $309.8M | ||
| Q2 25 | — | $198.8M | ||
| Q1 25 | $97.0M | $171.4M | ||
| Q4 24 | $98.9M | $412.6M | ||
| Q3 24 | $222.9M | $483.0M | ||
| Q2 24 | $173.3M | $376.9M | ||
| Q1 24 | $76.7M | $219.5M |
总债务ADUSOPCH
| Q4 25 | $121.0M | — | ||
| Q3 25 | $150.6M | $1.2B | ||
| Q2 25 | $169.1M | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $218.4M | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益ADUSOPCH
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $995.4M | $1.4B | ||
| Q4 24 | $970.5M | $1.4B | ||
| Q3 24 | $947.6M | $1.4B | ||
| Q2 24 | $921.7M | $1.4B | ||
| Q1 24 | $725.1M | $1.4B |
总资产ADUSOPCH
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $3.5B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.4B | $3.3B | ||
| Q4 24 | $1.4B | $3.4B | ||
| Q3 24 | $1.2B | $3.4B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.0B | $3.2B |
负债/权益比ADUSOPCH
| Q4 25 | 0.11× | — | ||
| Q3 25 | 0.14× | 0.86× | ||
| Q2 25 | 0.17× | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | 0.23× | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.8M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $130.2M |
| 自由现金流率自由现金流/营收 | 4.3% | 9.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.6% |
| 现金转化率经营现金流/净利润 | 0.63× | 2.69× |
| 过去12个月自由现金流最近4个季度 | $103.8M | $220.7M |
8季度趋势，按日历期对齐
经营现金流ADUSOPCH
| Q4 25 | $18.8M | — | ||
| Q3 25 | $51.3M | $139.4M | ||
| Q2 25 | $22.5M | $90.3M | ||
| Q1 25 | $18.9M | $-7.2M | ||
| Q4 24 | $10.4M | $36.1M | ||
| Q3 24 | $48.5M | $160.4M | ||
| Q2 24 | $18.8M | $195.7M | ||
| Q1 24 | $38.7M | $-68.8M |
自由现金流ADUSOPCH
| Q4 25 | $16.1M | — | ||
| Q3 25 | $49.3M | $130.2M | ||
| Q2 25 | $21.3M | $81.2M | ||
| Q1 25 | $17.1M | $-16.6M | ||
| Q4 24 | $8.7M | $25.8M | ||
| Q3 24 | $46.6M | $150.7M | ||
| Q2 24 | $17.7M | $185.9M | ||
| Q1 24 | $37.3M | $-74.6M |
自由现金流率ADUSOPCH
| Q4 25 | 4.3% | — | ||
| Q3 25 | 13.6% | 9.1% | ||
| Q2 25 | 6.1% | 5.7% | ||
| Q1 25 | 5.1% | -1.2% | ||
| Q4 24 | 2.9% | 2.0% | ||
| Q3 24 | 16.1% | 11.8% | ||
| Q2 24 | 6.2% | 15.1% | ||
| Q1 24 | 13.3% | -6.5% |
资本支出强度ADUSOPCH
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.4% | 0.6% | ||
| Q1 25 | 0.6% | 0.7% | ||
| Q4 24 | 0.6% | 0.8% | ||
| Q3 24 | 0.7% | 0.8% | ||
| Q2 24 | 0.4% | 0.8% | ||
| Q1 24 | 0.5% | 0.5% |
现金转化率ADUSOPCH
| Q4 25 | 0.63× | — | ||
| Q3 25 | 2.24× | 2.69× | ||
| Q2 25 | 1.02× | 1.79× | ||
| Q1 25 | 0.89× | -0.15× | ||
| Q4 24 | 0.53× | 0.60× | ||
| Q3 24 | 2.41× | 2.98× | ||
| Q2 24 | 1.04× | 3.69× | ||
| Q1 24 | 2.44× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
